35
Claris Biotherapeutics, Inc. files Form D
Company raise update · Raising · Offering $121.5M · Sold $55.7M · HALF MOON BAY, CA · filed 2026-08-12
55
Claris Biotherapeutics, Inc. raises $55.7M under Reg D
Company raise · Raising · HALF MOON BAY, CA · Form D filed 2026-08-07
$50M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Kenneth Harrison | Director |
| Henry Rath | Executive Officer |
| Brian Baum | Executive Officer |
| Marc de Garidel | Director |
| Clarke Atwell | Executive Officer |
| Meredith Fisher | Director |
| Matt Hobson | Director |
| Michael Dybbs | Director |
| Stephen Brady | Executive Officer, Director |
| Maha Radhakrishnan | Director |
| Susan Orr | Executive Officer |
| Reza Dana | Director |
Signed by Stephen Brady, President & Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
Claris Biotherapeutics, Inc. raises $2.3M under Reg D
Company raise · Closed · Offering $2.3M · Sold $2.3M · JERSEY CITY, NJ · filed 2025-09-22
45
Claris Biotherapeutics, Inc. raises $3.3M under Reg D
Company raise · Raising · Offering $3.3M · Sold $3.3M · JERSEY CITY, NJ · filed 2025-03-07